Parkinson's Disease: Drugs | Department of Health and Social Care | Written Answers As part of our concerted national efforts in response to the COVID-19 pandemic, we will continue doing everything we can to ensure patien
Tobacco | Department of Health and Social Care | Written Answers The Government has a legal commitment to undertake a Post Implementation Review (PIR) of the Tobacco and Related Product Regulations 2016
NHS: Ethnic Groups | Department of Health and Social Care | Written Answers Holding answer received on 29 June 2020 Public Health England (PHE) has not made a specific assessment of the benefit of conduc
Coronavirus: Israel | Department of Health and Social Care | Written Answers The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.
Coronavirus: Protective Clothing | Department of Health and Social Care | Written Answers The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period.
Overseas Aid | Department of Health and Social Care | Written Answers Holding answer received on 18 June 2020 The Secretary of State for Health and Social Care has many discussions with the Secreta
Cancer: Medical Treatments | Department of Health and Social Care | Written Answers Holding answer received on 25 June 2020 Since April 2015, the National Institute for Health and Care Excellence (NICE) has appr
Department of Health and Social Care: Overseas Aid | Department of Health and Social Care | Written Answers To address the most pressing global health challenges, the Department is delivering Official Development Assistance programmes which huge
Hepatitis: Public Health | Department of Health and Social Care | Written Answers Holding answer received on 25 June 2020 During 2018/19 Public Health England undertook a review of all the indicators within th
Cholesterol: Screening | Department of Health and Social Care | Written Answers NHS England and NHS Improvement have invested £9 million in an atrial fibrillation programme to test optimal care models and the role of
